Mitral Valve Prolapse
Also indexed as:MVP
This common heart condition caused by a valve abnormality can lead to occasional breathing problems. According to research or other evidence, the following self-care steps may be helpful.
About This Condition
The mitral valve is one of the four valves separating chambers of the heart. Mitral valve prolapse (MVP)
is a common and occasionally serious condition in which the cusp or cusps of the mitral valve bulge into one
of the heart chambers during the heart’s contraction. This bulging is caused by abnormalities in the
valve’s structure. When serious, mitral valve prolapse may progress to mitral regurgitation, where the
incompetent valve can no longer keep blood from leaking backwards into the wrong chamber of the heart.
Symptoms
Most people with MVP experience no symptoms. Some may experience difficulty breathing during exertion or when lying down, tremor, fatigue, lightheadedness, dizziness, and fainting. Some develop dull chest pain, palpitations (awareness of the heartbeat), anxiety, and other symptoms associated with the “fight or flight” response. When MVP causes these symptoms, it is referred to as dysautonomia syndrome.
Healthy Lifestyle Tips
People with dysautonomia symptoms should avoid stressful situations and should work on techniques for coping with stress.
Copyright © 2024 TraceGains, Inc. All rights reserved.
Learn more about TraceGains, the company.
The information presented by TraceGains is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. Self-treatment is not recommended for life-threatening conditions that require medical treatment under a doctor's care. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires December 2024.